MiMedx Group, Inc. (MDXG)
Largest Insider Buys in Sector
MDXG Stock Price History Chart
MDXG Stock Performance
About MiMedx Group, Inc.
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. Its products include EpiFix, a semi-permeable protective barrier membrane product used for the treatment of …
Insider Activity of MiMedx Group, Inc.
Over the last 12 months, insiders at MiMedx Group, Inc. have bought $35,787 and sold $659,218 worth of MiMedx Group, Inc. stock.
On average, over the past 5 years, insiders at MiMedx Group, Inc. have bought $338,110 and sold $837,315 worth of stock each year.
Highest buying activity among insiders over the last 12 months: DOUG RICE (Chief Financial Officer) — $71,573.
The last purchase of 5,000 shares for transaction amount of $35,787 was made by DOUG RICE (Chief Financial Officer) on 2023‑11‑21.
List of Insider Buy and Sell Transactions, MiMedx Group, Inc.
| 2024-03-13 | Sale | General Counsel and CAO | 20,381 0.0139% | $7.95 | $162,029 | -14.64% | ||
| 2024-02-20 | Sale | Chief Operating Officer | 15,271 0.0131% | $8.01 | $122,351 | -14.18% | ||
| 2024-02-16 | Sale | Chief Operating Officer | 15,493 0.0133% | $8.07 | $125,075 | -14.39% | ||
| 2024-02-15 | Sale | Chief Operating Officer | 15,198 0.013% | $8.06 | $122,496 | -16.20% | ||
| 2024-02-14 | Sale | Chief Operating Officer | 15,845 0.0132% | $8.03 | $127,267 | -14.37% | ||
| 2023-11-21 | Chief Financial Officer | 5,000 0.0043% | $7.16 | $35,787 | +3.26% | |||
| 2023-06-23 | Chief Executive Officer | 42,025 0.037% | $6.50 | $273,331 | +17.52% | |||
| 2023-06-22 | Chief Executive Officer | 57,975 0.0504% | $6.33 | $367,104 | +18.98% | |||
| 2023-05-16 | Sale | President, Regenerative Med. | 10,365 0.009% | $5.95 | $61,627 | +25.54% | ||
| 2023-05-15 | Sale | President, Regenerative Med. | 3,607 0.0032% | $6.15 | $22,170 | +23.76% | ||
| 2023-05-10 | Sale | Chief Financial Officer | 5,976 0.0051% | $5.93 | $35,414 | +23.60% | ||
| 2023-05-10 | Sale | General Counsel and CAO | 5,870 0.005% | $5.93 | $34,786 | +23.60% | ||
| 2023-05-10 | Sale | President, Regenerative Med. | 5,869 0.005% | $5.93 | $34,780 | +23.60% | ||
| 2023-05-10 | Sale | Chief Accounting Officer | 1,595 0.0014% | $5.93 | $9,452 | +23.60% | ||
| 2023-05-04 | Sale | President, Regenerative Med. | 51,756 0.0437% | $5.34 | $276,470 | +35.53% | ||
| 2023-05-02 | Sale | Chief Accounting Officer | 5,200 0.0045% | $3.80 | $19,739 | +96.59% | ||
| 2023-04-25 | Sale | Chief Financial Officer | 6,094 0.0054% | $3.74 | $22,816 | +104.64% | ||
| 2023-04-25 | Sale | General Counsel and CAO | 5,988 0.0054% | $3.74 | $22,419 | +104.64% | ||
| 2023-04-25 | Sale | President, Regenerative Med. | 5,987 0.0054% | $3.74 | $22,415 | +104.64% | ||
| 2023-04-25 | Sale | Chief Accounting Officer | 1,628 0.0015% | $3.74 | $6,095 | +104.64% |
Insider Historical Profitability
| DOUG RICE | Chief Financial Officer | 102200 0.0695% | $7.49 | 1 | 0 | |
| PETIT PARKER H | Chairman & CEO | 5009121 3.4088% | $7.49 | 9 | 1 | +25.79% |
| KOOB CHARLES E | director | 1312306 0.8931% | $7.49 | 3 | 1 | +51.39% |
| Eichler Kurt M | director | 574576 0.391% | $7.49 | 2 | 0 | |
| Taylor William Charles | President and COO | 467424 0.3181% | $7.49 | 1 | 19 | +61.76% |
Institutional Investor Ownership
| Essex Woodlands Management Inc | $217.1M | 19.1 | 28.2M | 0% | +$0 | 63.1 | |
| BlackRock | $70.6M | 6.21 | 9.17M | -3.82% | -$2.81M | <0.01 | |
| The Vanguard Group | $45.6M | 4.01 | 5.92M | -9.81% | -$4.96M | <0.01 | |
| State Street | $38.06M | 3.35 | 4.94M | +20.87% | +$6.57M | <0.01 | |
| Paradigm Capital Management Inc Ny | $30.1M | 2.65 | 3.91M | +13.94% | +$3.68M | 1.46 |